Eli Lilly lung cancer drug improves patient survival in trial

Home › Eli Lilly lung cancer drug improves patient survival in trial

Eli Lilly & Co.' s experimental lung cancer medicine increased survival among patients taking the drug compared with those on chemotherapy alone.

01.07	Hurricane Beryl Graphics
01.07	Hurricane Beryl Public Advisory Number 11A
01.07	Summary for Hurricane Beryl (AT2/AL022024)
01.07	Atlantic Tropical Weather Outlook
01.07	Eastern North Pacific Tropical Weather Outlook
01.07	Tropical Depression Chris Graphics
01.07	Tropical Depression Chris Public Advisory Number 3A
01.07	Union expected to call off Port Talbot strike action
More »

je.st